Tumor promoter-mediated inhibition of cell differentiation: suppression of the expression of erythroid functions in murine erythroleukemia cells.
about
Identification and assessment of tumor-oromoting and cocarcinogenic agents: state-of-the-art in vitro methodsNuclear proteins that bind the human gamma-globin gene promoter: alterations in binding produced by point mutations associated with hereditary persistence of fetal hemoglobin.Protein kinase C activity and hexamethylenebisacetamide-induced erythroleukemia cell differentiationPhorbol diesters stimulate the development of an early murine progenitor cell. The burst-forming unit-megakaryocyte.Tumor promoters stimulate hyperplasia of microtubule organizing center and inhibit DNA synthesis in cultured cells.Induced differentiation of erythroleukemia cells by hexamethylene bisacetamide: a model for cytodifferentiation of transformed cells.The 1985 Walter Hubert lecture. Malignant cell differentiation as a potential therapeutic approach.Continuous suppression of globin gene expression and differentiation of Friend erythroleukemia cells by phorbol 12-myristate 13-acetate (PMA) despite the loss of PMA binding sites by down regulation.Inducer-mediated commitment of murine erythroleukemia cells to terminal cell division: the expression of commitmentInducer-mediated commitment of murine erythroleukemia cells to differentiation: a multistep process.Tumor promoters enhance myeloid and erythroid colony formation by normal mouse hemopoietic cells.Transcriptional regulation of a tumor promoter and mitogen-inducible gene in human lymphocytesAntagonism between epidermal growth factor and phorbol ester tumor promoters in human breast cancer cells.Alternative transcription and splicing of the human porphobilinogen deaminase gene result either in tissue-specific or in housekeeping expression.Regeneration and the mechanism of epidermal tumor promotion.Regulation and expression of a growth arrest-specific gene (gas5) during growth, differentiation, and development.
P2860
Q23914589-906F646D-613C-4848-AFCB-C8AF022D282DQ33358166-158F7E0A-349D-4253-A14A-C74900D7C426Q34333850-87F7B783-6C96-4E68-890E-487C3647776DQ34547089-0EFDF652-44FA-47B1-92E3-BBEADD3B9185Q34616386-B74FE839-239C-4C90-BB4F-FF8651D807F2Q35032944-F5A38322-65CE-46CA-A7E7-10BD301C139AQ35992543-8B7FEA73-0E9E-4008-A3F5-EF0F0267430DQ36266322-B5381944-196C-4338-9E59-89D00CE477E4Q36269169-5AF3C1BC-21BE-4B19-BC78-620019B03308Q36277743-0C633AC9-B5E3-48B3-A66B-71078F1CCF94Q36398238-29088ED9-560E-4FAD-9196-1BE1FCB8FF74Q36950351-92E0B412-E3FC-4116-9DC9-CE25A7B49FB6Q36997119-4D0AEB2F-816C-4476-9CFA-232C624B044EQ37479183-FF4E7FC9-177C-4709-AD21-691F588018E8Q39824544-FED86A2C-A5C8-4487-B23A-C83EFDBC0ABEQ40655817-A86A898B-C6A6-485A-AA26-2293C79902B6
P2860
Tumor promoter-mediated inhibition of cell differentiation: suppression of the expression of erythroid functions in murine erythroleukemia cells.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 1979
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Tumor promoter-mediated inhibi ...... murine erythroleukemia cells.
@en
Tumor promoter-mediated inhibi ...... murine erythroleukemia cells.
@nl
type
label
Tumor promoter-mediated inhibi ...... murine erythroleukemia cells.
@en
Tumor promoter-mediated inhibi ...... murine erythroleukemia cells.
@nl
prefLabel
Tumor promoter-mediated inhibi ...... murine erythroleukemia cells.
@en
Tumor promoter-mediated inhibi ...... murine erythroleukemia cells.
@nl
P2093
P2860
P356
P1476
Tumor promoter-mediated inhibi ...... murine erythroleukemia cells.
@en
P2093
Maniatis G
Rifkind RA
P2860
P304
P356
10.1073/PNAS.76.4.1906
P407
P577
1979-04-01T00:00:00Z